Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection - PubMed (original) (raw)
. 1996 Feb 15;156(4):1436-41.
Affiliations
- PMID: 8568245
Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection
C M Walsh et al. J Immunol. 1996.
Abstract
Tumor cells insensitive to lysis through the Fas and TNF pathways were injected either subcutaneously or into the peritoneal cavities of allogeneic perforin-less (P0) and perforin wild-type (P2) mice. In three of four cases, the tumors were rejected equally rapidly in both strains of mice. Rejection was accompanied by vigorous in vitro cytotoxicity in P2, but not in P0 mice. The rapid clearance of allografted cells in mice where all three known cytolytic pathways are seriously compromised raises important questions about the involvement of cell-mediated cytotoxicity, as defined by current assay techniques, in primary allograft rejection.
Similar articles
- Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER. Lee RK, et al. J Immunol. 1996 Sep 1;157(5):1919-25. J Immunol. 1996. PMID: 8757310 - Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K. Kataoka T, et al. J Immunol. 1996 May 15;156(10):3678-86. J Immunol. 1996. PMID: 8621902 - Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice.
Baker MB, Podack ER, Levy RB. Baker MB, et al. Biol Blood Marrow Transplant. 1995 Dec;1(2):69-73. Biol Blood Marrow Transplant. 1995. PMID: 9118294 - Cell-mediated cytotoxicity.
Doherty PC. Doherty PC. Cell. 1993 Nov 19;75(4):607-12. doi: 10.1016/0092-8674(93)90480-e. Cell. 1993. PMID: 7694805 Review. No abstract available. - Cellular events within the rejecting allograft.
Ascher NL, Hoffman R, Hanto DW, Simmons RL. Ascher NL, et al. Transplantation. 1983 Mar;35(3):193-7. Transplantation. 1983. PMID: 6340271 Review. No abstract available.
Cited by
- Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes.
Jensen ER, Glass AA, Clark WR, Wing EJ, Miller JF, Gregory SH. Jensen ER, et al. Infect Immun. 1998 Sep;66(9):4143-50. doi: 10.1128/IAI.66.9.4143-4150.1998. Infect Immun. 1998. PMID: 9712760 Free PMC article. - Recognizing Complexity of CD8 T Cells in Transplantation.
Nicosia M, Valujskikh A. Nicosia M, et al. Transplantation. 2024 Nov 1;108(11):2186-2196. doi: 10.1097/TP.0000000000005001. Epub 2024 Apr 19. Transplantation. 2024. PMID: 38637929 Review. - Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection.
Henriques-Pons A, Oliveira GM, Paiva MM, Correa AF, Batista MM, Bisaggio RC, Liu CC, Cotta-De-Almeida V, Coutinho CM, Persechini PM, Araujo-Jorge TC. Henriques-Pons A, et al. Int J Exp Pathol. 2002 Apr;83(2):67-79. doi: 10.1046/j.1365-2613.2002.00215.x. Int J Exp Pathol. 2002. PMID: 12084043 Free PMC article. - Loss of DRAK2 signaling enhances allogeneic transplant survival by limiting effector and memory T cell responses.
Weist BM, Hernandez JB, Walsh CM. Weist BM, et al. Am J Transplant. 2012 Aug;12(8):2220-7. doi: 10.1111/j.1600-6143.2012.04056.x. Epub 2012 Apr 11. Am J Transplant. 2012. PMID: 22494341 Free PMC article. - IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.
Zhang B, Karrison T, Rowley DA, Schreiber H. Zhang B, et al. J Clin Invest. 2008 Apr;118(4):1398-404. doi: 10.1172/JCI33522. J Clin Invest. 2008. PMID: 18317595 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous